FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3007029762> ?p ?o ?g. }

• W3007029762 abstract "Abstract Background Parenteral nutrition (PN) is essential for survival in infants with intestinal failure (IF). PN-associated cholestasis (PNAC) and liver disease (PNALD) are life-threatening complications of long-term PN use. SMOFlipid (soybean oil, medium-chain triglycerides, olive oil, and fish oil) has recently been approved as an off-label alternative to the conventional soy-based lipid emulsion (Intralipid). It is thought to have anti-cholestatic properties due to its more diverse lipid composition. Due to its’ recent approval in Canada (2013) and the USA (2016), data remains sparse. Aims We aim to determine if infants with IF receiving SMOFlipid had significantly lower rates of PNAC and improved growth compared to those receiving Intralipid. Methods All patients (≤1 year old at start of PN therapy) who received PN of any duration at two tertiary pediatric hospitals in Edmonton (2010–2018) were identified from the shared pharmacy database. Those with IF who received one type of PN continuously for ≥6 weeks total were included. Individuals with an initial serum conjugated bilirubin &gt;50 µmol/L and/or who had PN interruptions &gt;5 days were excluded. Data on liver parameters, growth, and complications were collected. Non-parametric tests (Mann-Whitney U test for continuous variables and χ2 test for categorical variables) were used to compare PNAC/PNALD (serum conjugated bilirubin &gt;34umol/L during PN) and growth (weight/length/head circumference z-scores) between SMOFlipid and Intralipid. Results 1777 patients were reviewed; 40 infants (55% male), median age 4 weeks (range 0–48 weeks) at the time of PN initiation, met the inclusion criteria. Reasons for exclusion (n=1737) were receiving PN &lt;6 weeks total (n=1485), duplicate patients (n=154), receiving multiple types of PN with each less than 6 weeks total (n=62), an initial serum conjugated bilirubin &gt;50umol/L (n=21), more than 5 consecutive days off of PN (n=12), and older than 1 year old at time of PN initiation (n=3). Twenty-one patients (53%) received SMOFlipid, 15 (38%) Intralipid, and 4 (10%) Omegaven for ≥6 weeks. The majority (92%) were in an intensive care unit (neonatal or pediatric). No patients were septic when starting PN. Individuals received PN over a median of 7.9 weeks (range 6–27 weeks). Conclusions As expected, neonatal onset intestinal failure is rare in Edmonton. In our tertiary pediatric institutions, 2010–2018, SMOFLipid was the predominant lipid choice for infants with intestinal failure, followed by Intralipid. Omegaven was used rarely. This dataset will now allow us to compare the rates of PNAC at six weeks post-PN initiation and differences in growth between infants with IF receiving SMOFlipid versus the traditional Intralipid in our Canadian setting. Analysis is currently underway. Funding Agencies Women and Children’s Health Research Institute (WCHRI) at the University of Alberta" @default.
• W3007029762 created "2020-03-06" @default.
• W3007029762 creator A5009632654 @default.
• W3007029762 creator A5044541811 @default.
• W3007029762 creator A5048795884 @default.
• W3007029762 creator A5087540348 @default.
• W3007029762 date "2020-02-01" @default.
• W3007029762 modified "2023-09-26" @default.
• W3007029762 title "A134 RATES OF PARENTERAL NUTRITION-ASSOCIATED CHOLESTASIS/LIVER DISEASE AND GROWTH PRE- AND POST-SMOFLIPID INTRODUCTION IN NEONATES AND INFANTS WITH INTESTINAL FAILURE" @default.
• W3007029762 doi "https://doi.org/10.1093/jcag/gwz047.133" @default.
• W3007029762 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7043517" @default.
• W3007029762 hasPublicationYear "2020" @default.
• W3007029762 type Work @default.
• W3007029762 sameAs 3007029762 @default.
• W3007029762 citedByCount "0" @default.
• W3007029762 crossrefType "journal-article" @default.
• W3007029762 hasAuthorship W3007029762A5009632654 @default.
• W3007029762 hasAuthorship W3007029762A5044541811 @default.
• W3007029762 hasAuthorship W3007029762A5048795884 @default.
• W3007029762 hasAuthorship W3007029762A5087540348 @default.
• W3007029762 hasBestOaLocation W30070297621 @default.
• W3007029762 hasConcept C126322002 @default.
• W3007029762 hasConcept C141071460 @default.
• W3007029762 hasConcept C187212893 @default.
• W3007029762 hasConcept C2777075537 @default.
• W3007029762 hasConcept C2777513400 @default.
• W3007029762 hasConcept C2778593092 @default.
• W3007029762 hasConcept C2779243279 @default.
• W3007029762 hasConcept C2779399885 @default.
• W3007029762 hasConcept C2779609443 @default.
• W3007029762 hasConcept C2779820108 @default.
• W3007029762 hasConcept C2779946292 @default.
• W3007029762 hasConcept C2780890998 @default.
• W3007029762 hasConcept C2909208804 @default.
• W3007029762 hasConcept C2911091166 @default.
• W3007029762 hasConcept C3018696549 @default.
• W3007029762 hasConcept C505870484 @default.
• W3007029762 hasConcept C71924100 @default.
• W3007029762 hasConcept C78722104 @default.
• W3007029762 hasConcept C86803240 @default.
• W3007029762 hasConcept C90924648 @default.
• W3007029762 hasConceptScore W3007029762C126322002 @default.
• W3007029762 hasConceptScore W3007029762C141071460 @default.
• W3007029762 hasConceptScore W3007029762C187212893 @default.
• W3007029762 hasConceptScore W3007029762C2777075537 @default.
• W3007029762 hasConceptScore W3007029762C2777513400 @default.
• W3007029762 hasConceptScore W3007029762C2778593092 @default.
• W3007029762 hasConceptScore W3007029762C2779243279 @default.
• W3007029762 hasConceptScore W3007029762C2779399885 @default.
• W3007029762 hasConceptScore W3007029762C2779609443 @default.
• W3007029762 hasConceptScore W3007029762C2779820108 @default.
• W3007029762 hasConceptScore W3007029762C2779946292 @default.
• W3007029762 hasConceptScore W3007029762C2780890998 @default.
• W3007029762 hasConceptScore W3007029762C2909208804 @default.
• W3007029762 hasConceptScore W3007029762C2911091166 @default.
• W3007029762 hasConceptScore W3007029762C3018696549 @default.
• W3007029762 hasConceptScore W3007029762C505870484 @default.
• W3007029762 hasConceptScore W3007029762C71924100 @default.
• W3007029762 hasConceptScore W3007029762C78722104 @default.
• W3007029762 hasConceptScore W3007029762C86803240 @default.
• W3007029762 hasConceptScore W3007029762C90924648 @default.
• W3007029762 hasLocation W30070297621 @default.
• W3007029762 hasLocation W30070297622 @default.
• W3007029762 hasOpenAccess W3007029762 @default.
• W3007029762 hasPrimaryLocation W30070297621 @default.
• W3007029762 hasRelatedWork W11437255 @default.
• W3007029762 hasRelatedWork W12742693 @default.
• W3007029762 hasRelatedWork W16783340 @default.
• W3007029762 hasRelatedWork W19569700 @default.
• W3007029762 hasRelatedWork W20529617 @default.
• W3007029762 hasRelatedWork W21241640 @default.
• W3007029762 hasRelatedWork W3338963 @default.
• W3007029762 hasRelatedWork W5070378 @default.
• W3007029762 hasRelatedWork W5547121 @default.
• W3007029762 hasRelatedWork W17947238 @default.
• W3007029762 isParatext "false" @default.
• W3007029762 isRetracted "false" @default.
• W3007029762 magId "3007029762" @default.
• W3007029762 workType "article" @default.